SPRY UPCOMING DEADLINE: SueWallSt Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firm
Allegations focus on ARS Pharmaceuticals' alleged failure to disclose the risk that CVS Caremark's rigid formulary system could push a neffy coverage decision to January 2027, missing the summer and back-to-school allergy seasons. NEW YORK, Sept. 3, 2026 /PRNewswire/ -- "Investors deserve...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is down 23.8% since this was published, 49 days ago.
- CVS Health is down 2.8% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.